LATEST
EQT agreed to acquire CleanawaynewNavigator Gas / Navigator HoldingsAlcoa / AliGroupInternational Seaways agreed to acquire BrutonBoston Crest PVT / LQR HouseBrady acquired Productivity Solutions and Services businessJMSB / EFSIVista Equity Partners / PKI Business UnitBluegem Capital Partners / Rispo GroupApax Partners agreed to acquire OdidoGTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire Stockbridge
Open App
ClosedPublished 13 Nov 2025

Salarius Pharmaceuticals /
Decoy

Salarius Pharmaceuticals adds the Decoy business through merger

Buy side: Salarius Pharmaceuticals
Buy sideSalarius Pharmaceuticals
Target: Decoy
TargetDecoy
Salarius Pharmaceuticals, Inc. · 13 Nov 2025Source
See the source
Buy side: Salarius Pharmaceuticals
Buy sideSalarius Pharmaceuticals
Target: Decoy
TargetDecoy
01 / BuyerSalarius Pharmaceuticals
02 / TargetDecoy
Source for the buyer and target: Salarius Pharmaceuticals, Inc.

For the buyer and target.

“(November 13, 2025) – Salarius Pharmaceuticals (Nasdaq: SLRX) (“Salarius” or the “Company”) and Decoy Therapeutics (“Decoy”) announce the completion of their strategic merger with the combined company now focused on advancing Decoy’s pipeline of peptide conjugate therapeutics engineered through its IMP 3 ACT platform that reduces the complexity of drug development and manufacturing.”

Published 13 Nov 2025

Open the source
01

What happened

On Nov. 12, 2025, Salarius Pharmaceuticals, Inc. completed its merger with Decoy. The Decoy business became a wholly owned subsidiary of the Company. [01]

The filing does not state a transaction value. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals adds the Decoy business through merger

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Deadline

    “Salarius Pharmaceuticals adds the Decoy business through merger On Nov. 12, 2025, Salarius Pharmaceuticals, Inc. completed its merger with Decoy”

    Open the source

  2. Published by Salarius Pharmaceuticals, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.